Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sensitive Pulmonary Tuberculosis”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Testing effectiveness (Phase 2)Study completedNCT03563599
What this trial is testing

Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

Who this might be right for
Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB
Qurient Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01225640
What this trial is testing

PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

Who this might be right for
Tuberculosis
Sequella, Inc. 59
Not applicableUnknownNCT05110950
What this trial is testing

Endobronchial Ultrasound Needle Aspiration With and Without Suction

Who this might be right for
Mediastinal LymphadenopathyHilar LymphadenopathyLymphoma+7 more
Università Politecnica delle Marche 306
Testing effectiveness (Phase 2)UnknownNCT04670120
What this trial is testing

Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166)

Who this might be right for
Sensitive Pulmonary Tuberculosis
Beijing Chest Hospital 56
Not applicableNot Yet RecruitingNCT06921278
What this trial is testing

Development of the Drug and Alcohol Respiratory Health Test

Who this might be right for
Respiratory DiseaseSubstance-Related DisordersCOPD+6 more
King's College London 260
Not applicableLooking for participantsNCT07164742
What this trial is testing

Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)

Who this might be right for
TB - TuberculosisTBTB Infection
Johns Hopkins University 690
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Not applicableLooking for participantsNCT06347939
What this trial is testing

Mediastinal EBUS Cryobiopsy Study In Sweden

Who this might be right for
Mediastinal LymphadenopathyLung CancerSarcoidosis+2 more
Region Skane 200
Testing effectiveness (Phase 2)UnknownNCT06224036
What this trial is testing

Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Drug-resistant Tuberculosis
Beijing Chest Hospital 52
Not applicableUnknownNCT00932854
What this trial is testing

A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)

Who this might be right for
Isolated Mediastinal LymphadenopathySarcoidosisTuberculosis+2 more
University College London Hospitals 75
Not applicableStudy completedNCT04743583
What this trial is testing

Prevalence and Malignant Involvement of Calcified Intrathoracic Lymph Nodes in Patients Undergoing Endosonography

Who this might be right for
LymphadenopathyLung CancerSarcoidosis+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 362
Large-scale testing (Phase 3)Study completedNCT01955824
What this trial is testing

A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy

Who this might be right for
Lung CancerTuberculosisSarcoidosis+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 500
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Post-approval studies (Phase 4)Not Yet RecruitingNCT06654934
What this trial is testing

Prednisolone for 12 Versus 6 Months to Treat Pulmonary Sarcoidosis

Who this might be right for
Sarcoidosis
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Testing effectiveness (Phase 2)Looking for participantsNCT07525427
What this trial is testing

Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis

Who this might be right for
Drug Susceptible Pulmonary Tuberculosis
Gates Medical Research Institute 150
Not applicableStudy completedNCT05628454
What this trial is testing

Comparison of Three Different Puncture Techniques in EBUS-TBNA

Who this might be right for
Lung CancerSarcoidosisTuberculosis
Beijing Friendship Hospital 75
Large-scale testing (Phase 3)Looking for participantsNCT07209761
What this trial is testing

Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Testing effectiveness (Phase 2)UnknownNCT05926466
What this trial is testing

BTZ-043 Dose Evaluation in Combination and Selection

Who this might be right for
Tuberculosis, PulmonaryOther Specified Pulmonary Tuberculosis
Michael Hoelscher 90
Testing effectiveness (Phase 2)Looking for participantsNCT07672405
What this trial is testing

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Who this might be right for
Tuberculosis, Pulmonary
Global Alliance for TB Drug Development 100
Testing effectiveness (Phase 2)Study completedNCT01498419
What this trial is testing

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 207
Next Page